195 Results for "

Val-Cit

" in MedChemExpress (MCE) Product Catalog:
Products (195)

195 Results for "Val-Cit" in MCE Product Catalog:

97
97 Publications Verification
Cat. No.: HY-15575
CAS No.: 646502-53-6
Purity:  99.94%
Synonyms: MC-Val-Cit-PAB-MMAE; mc-vc-PAB-MMAE; Vedotin
VcMMAE (mc-vc-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-131296
CAS No.: 2677841-58-4
Purity:  98.98%
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

5-A-RU-PABC-Val-Cit-Fmoc is the proagent of 5-A-RU . 5-A-RU, a precursor of bacterial Riboflavin, is a mucosal-associated invariant T (MAIT) cells activator. 5-A-RU forms potent MAIT-activating antigens via non-enzymatic reactions with small molecules, such as glyoxal and methylglyoxal, which are derived from other metabolic pathways .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-20336
CAS No.: 159857-81-5
Synonyms: Maleimidocaproyl-L-Valine-L-Citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate
Target:  

ADC Linkers

Research Areas:  

Others Inflammation/Immunology Cancer

Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112786
CAS No.: 863971-17-9
Purity:  98.16%
Synonyms: Vc-MMAF
Research Areas:  

Cancer

MC-Val-Cit-PAB-MMAF (Vc-MMAF) is a drug-linker conjugate for ADC by using the tubulin inhibitor, MMAF (HY-15579), linked via cathepsin cleavable MC-Val-Cit-PAB (HY-78738). MC-Val-Cit-PAB-MMAF shows antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100566
Purity:  99.24%
Research Areas:  

Cancer

SuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100374
CAS No.: 644981-35-1
Purity:  99.76%
Research Areas:  

Cancer

Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE (HY-15162). MMAE a potent mitotic inhibitor by inhibiting tubulin polymerization.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145929
CAS No.: 2504068-28-2
Purity:  99.57%
Synonyms: MC-Val-Cit-PAB-DX8951
Research Areas:  

Cancer

MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12362
CAS No.: 159857-79-1
Purity:  99.64%
Target:  

ADC Linkers

Research Areas:  

Cancer

Val-cit-PAB-OH is a degradable ADC linker.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128904
CAS No.: 2055896-98-3
Purity:  98.77%
Research Areas:  

Cancer

MC-Val-Cit-PAB-duocarmycin chloride is a agent-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker MC-Val-Cit-PAB.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128902
CAS No.: 2055896-92-7
Purity:  92.87%
Research Areas:  

Cancer

MC-Val-Cit-PAB-vinblastine is a agent-linker conjugate for ADC with potent antitumor activity by using vinblastine (an microtubule protein inhibitor), linked via the ADC linker MC-Val-Cit-PAB.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W190943
CAS No.: 1869126-64-6
Research Areas:  

Cancer

Azido-PEG4-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker Azido-PEG4-Val-Cit-PAB-OH . Azido-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-140145
CAS No.: 2112738-09-5
Purity:  96.19%
Target:  

ADC Linkers

Research Areas:  

Cancer

Mal-PEG4-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141154
CAS No.: 1492056-71-9
Purity:  99.93%
Research Areas:  

Cancer

Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141155
CAS No.: 2762519-08-2
Purity:  99.95%
Research Areas:  

Cancer

endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable ADC linker conjugated with drug containing 4-unit PEG, which can be used for synthesizing antibody-drug conjugates (ADCs). endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99016A
CAS No.: 1346452-25-2
Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate. Enfortumab vedotin-ejfv is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE (HY-15162) via a protease-cleavable Val-Cit linker. The antibody portion is Enfortumab (HY-P99016), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Nectin-4 is an adhesion protein involved in cellular processes and tumorigenesis, and Enfortumab vedotin-ejfv is indicated for the inhibition of locally advanced or metastatic urothelial carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99016B
CAS No.: 1346452-25-2

Research Areas:  

Cancer

Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate (ADC). Enfortumab vedotin-ejfv (solution) is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE (HY-15162) via a protease-cleavable Val-Cit linker. The antibody portion is Enfortumab (HY-P99016), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Nectin-4 is an adhesion protein involved in cellular processes and tumorigenesis, and Enfortumab vedotin-ejfv (solution) is indicated for the inhibition of locally advanced or metastatic urothelial carcinoma .
loading...
    loading...
Cat. No.: HY-41189
CAS No.: 863971-53-3
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers .
loading...
    loading...
Cat. No.: HY-19318
CAS No.: 159858-22-7
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
loading...
    loading...
Cat. No.: HY-140014
CAS No.: 159858-33-0
Purity:  99.38%
Target:  

ADC Linkers

Research Areas:  

Cancer

Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-130989
CAS No.: 1895916-24-1
Purity:  95.02%
Synonyms: NHS-Glutarate-Val-Cit-PAB-MMAE
Research Areas:  

Cancer

SuO-Glu-Val-Cit-PAB-MMAE (NHS-Glutarate-Val-Cit-PAB-MMAE) consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...